Pediatric invasive mucormycosis cured with high dose liposomal amphotericin B;Yüksek doz lipozomal amfoterisin B ile kür saǧlanan çocukluk çaǧı invaziv mukormikozis

Tuberkuloz ve Toraks

Volumn 60, Issue 4, 2012, Pages 375-379

  Erbey, Fatih ^a   Kocabaş, Emine ^a   Bayram, Ibrahim ^a   Soyupak, Süreyya ^a   Gümürdülü, Derya ^a   Tanyeli, Atila ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Childhood; Invasive pulmonary fungal infection; Liposomal amphotericin B

Indexed keywords

AMIKACIN; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ASPARAGINASE; CEFTAZIDIME; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; MEROPENEM; METHOTREXATE; VANCOMYCIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APHTHOUS STOMATITIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILD; DRUG DOSE INCREASE; EDEMA; FEBRILE NEUTROPENIA; FEVER; FOLLOW UP; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LUNG NODULE; MALE; MUCORMYCOSIS; ORAL BIOPSY; PATHOLOGY; PULMONARY MUCORMYCOSIS; SCHOOL CHILD; SWELLING; TACHYPNEA; TOMOGRAPHY;

EID: 84872198679     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: 10.5578/tt.2364     Document Type: Article

References (15)

1. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004; 10 (Suppl 1): 31-47.
2. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses 2001; 44: 253-60.
3. Nosari A, Oreste P, Montillo M, Carrafiello G, Draisci M, Muti G, et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica 2000; 85: 1068-71.
4. Funada H, Matsuda T. Pulmonary mucormycosis in a hematology ward. Intern Mewd 1996; 35: 540-4.
5. Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto). Br J Haematol 1997; 99: 331-6.
6. Ribes JA, Vonover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236-301.
7. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the last 30 years. Arch Intern Med 1999; 159: 1301-9.
8. Chopra R. Ambisome in the treatment of fungal infections. The UK experience. J Antimicrob Chemother 2002; 49: 43-7.
9. Richardson M, Ellis M. Clinical and laboratory diagnosis. Hosp Med 2000; 61: 610-4.
10. Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994; 57: 1044-50.
11. Donado-Una JR, Diaz-Hellin V, Lopez-Encuentra A, Echave-Sustaeta JM. Persistent cavitations in pulmonary mucormycosis after apparently successful amphotericin B. Eur J Cardiothorac Surg 2002; 21: 940-2.
12. Ringden O, Meunier F, Tollemar J, Ricci P, Tura S, Kuse E, et al. Efficacy of amphotericin B encapsulated in liposomes (Am-Bisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother 1991; 28(Suppl B): 73-82.
13. Cagatay AA, Oncü SS, Calangu SS, Yildirmak TT, Ozsüt HH, Eraksoy HH. Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report. BMC Infect Dis 2001; 1: 22.
14. Maury S, Leblanc T, Feuilhade M, Molina JM, Schaison G. Successful treatment of disseminated mucormycosis with liposomal amphotericin B and surgery in a child with leukemia. Clin Infect Dis 1998; 26: 200-2.
15. nd, Ritchie DJ, Mundy LM. Rhinocerebral mucormycosis in the era of lipidbased amphotericin B: case report and literature review. Pharmacotherapy 2002; 22: 519-26.